Literature DB >> 30855658

Preclinical Alzheimer Disease and the Dawn of the Pre-Caregiver.

Emily A Largent1,2, Jason Karlawish1,3.   

Abstract

Entities:  

Mesh:

Year:  2019        PMID: 30855658      PMCID: PMC7171977          DOI: 10.1001/jamaneurol.2019.0165

Source DB:  PubMed          Journal:  JAMA Neurol        ISSN: 2168-6149            Impact factor:   18.302


× No keyword cloud information.
  4 in total

1.  Monetary costs of dementia in the United States.

Authors:  Michael D Hurd; Paco Martorell; Adeline Delavande; Kathleen J Mullen; Kenneth M Langa
Journal:  N Engl J Med       Date:  2013-04-04       Impact factor: 91.245

Review 2.  NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.

Authors:  Clifford R Jack; David A Bennett; Kaj Blennow; Maria C Carrillo; Billy Dunn; Samantha Budd Haeberlein; David M Holtzman; William Jagust; Frank Jessen; Jason Karlawish; Enchi Liu; Jose Luis Molinuevo; Thomas Montine; Creighton Phelps; Katherine P Rankin; Christopher C Rowe; Philip Scheltens; Eric Siemers; Heather M Snyder; Reisa Sperling
Journal:  Alzheimers Dement       Date:  2018-04       Impact factor: 21.566

3.  Study partners: essential collaborators in discovering treatments for Alzheimer's disease.

Authors:  Emily A Largent; Jason Karlawish; Joshua D Grill
Journal:  Alzheimers Res Ther       Date:  2018-09-27       Impact factor: 6.982

Review 4.  A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers.

Authors:  Clifford R Jack; David A Bennett; Kaj Blennow; Maria C Carrillo; Howard H Feldman; Giovanni B Frisoni; Harald Hampel; William J Jagust; Keith A Johnson; David S Knopman; Ronald C Petersen; Philip Scheltens; Reisa A Sperling; Bruno Dubois
Journal:  Neurology       Date:  2016-07-01       Impact factor: 9.910

  4 in total
  5 in total

1.  Translational Neuroethics: A Vision for a More Integrated, Inclusive, and Impactful Field.

Authors:  Anna Wexler; Laura Specker Sullivan
Journal:  AJOB Neurosci       Date:  2021-12-01

2.  Is Reluctance to Share Alzheimer's Disease Biomarker Status with a Study Partner a Barrier to Preclinical Trial Recruitment?

Authors:  C G Cox; M M Ryan; D L Gillen; J D Grill
Journal:  J Prev Alzheimers Dis       Date:  2021

3.  Cognitively unimpaired adults' reactions to disclosure of amyloid PET scan results.

Authors:  Emily A Largent; Kristin Harkins; Christopher H van Dyck; Sara Hachey; Pamela Sankar; Jason Karlawish
Journal:  PLoS One       Date:  2020-02-13       Impact factor: 3.240

4.  Family members' perspectives on learning cognitively unimpaired older adults' amyloid-β PET scan results.

Authors:  Emily A Largent; Maramawit Abera; Kristin Harkins; Sara J Feldman; Wendy R Uhlmann; J Scott Roberts; Jason Karlawish
Journal:  J Am Geriatr Soc       Date:  2021-07-12       Impact factor: 5.562

5.  Effects of comprehensive intervention on life quality among the elderly with Alzheimer Disease and their caregivers based on mixed models.

Authors:  Li Yang; Cheng Xuan; Caiyan Yu; Xiaoqing Jin; Pinpin Zheng; Jing Yan
Journal:  Nurs Open       Date:  2021-05-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.